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Summary
QUESTIONS UNDER STUDY: To update the prevalence
of vitamin D insufficiency and to identify factors associ-
ated with vitamin D status in the Swiss adult population.
METHODS: Data from the 2010–2011 Swiss Study on Salt
intake, a population-based study in the Swiss population,
was used. Vitamin D concentration in serum was measured
by liquid chromatography- tandem mass spectrometry. Ma-
jor factors that influence vitamin D levels were taken into
account. Survey statistical procedures were used to estim-
ate means and prevalences of vitamin D levels and status.
Monthly-specific tertiles of vitamin D and ordinal logistic
regression were used to determine the associations of cov-
ariates of interest with vitamin D status.
RESULTS: The prevalences of vitamin D insufficiency
(serum 25-hydroxyvitamin D: 20–29.9 ng/ml) and defi-
ciency (<20 ng/ml) were the highest in the January-March
period; 26.4% (95%CI: 21.6–31.7) and 61.6% (95%CI:
56.0–67.0), respectively. In the same period, more than 9
Abbreviations:
BMI body mass index
CKD-EPI chronic kidney disease epidemiology collaboration
equation
CVD cardiovascular disease
DEQAS vitamin D external quality assessment scheme
IS international standards
LC-MS/MS liquid chromatography-tandem mass spectrometry
NHANES National Health and Nutrition Examination Survey
SSS Swiss Study on Salt intake
25(OH)D 25-hydroxyvitamin D
UVB ultraviolet B
of ten men were vitamin D insufficient or deficient. Each
unit increase of Body Mass Index was associated with an
8% decreased likelihood of being in a higher vitamin D ter-
tiles. Oral contraceptive, altitude, urinary excretion of cal-
cium, use of vitamin D supplement or treatment, high wine
consumption, physical activity were associated with vitam-
in D tertiles. Compared to the French-speaking region, the
Italian-speaking region was independantly associated with
a higher likelihood of being in higher vitamin D tertiles
(OR: 1.66, 95%CI: 1.14–2.43).
CONCLUSIONS: Low levels of vitamin D are common
among Swiss adults, in particular during winter months and
outside the Italian-speaking region.
Key words: vitamin D; serum; population; Switzerland;
deficiency
Introduction
Vitamin D deficiency is associated with rickets and osteo-
porosis [1, 2]. More recently, epidemiological associations
of vitamin D deficiency with other diseases such as can-
cers, multiple sclerosis, and rheumatoid arthritis have been
reported [3]. There is also evidence from molecular, animal
and human studies suggesting that vitamin D level is asso-
ciated with cardiovascular disease (CVD) [4], diabetes [5,
6], and depression [7].
In humans, most of the circulating vitamin D is synthetised
from cholesterol following exposure to sunlight ultraviolet
B (UVB), whereas a smaller amount is derived from diet
and dietary supplements. Diet contributes only between
10% to 20% to 25(OH)D levels, but becomes more import-
ant when sunshine exposure is low [8]. Fish is the major
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dietary source of vitamin D in humans. For example, 85
grams of cooked salmon provide 90% of the recommen-
ded daily vitamin D intake, whereas 85 grams of cooked
beef provide only 4% of the recommended intake [9]. Oth-
er factors such as body mass index (BMI), skin pigmenta-
tion, and geographical factors (e.g., latitude, altitude, met-
eorological conditions) can influence circulating vitamin D
levels [10].
Serum 25-hydroxyvitamin D [25(OH)D] is the major cir-
culating form of vitamin D that is used to determine vitam-
in D status. Vitamin D deficiency and insufficiency are re-
spectively defined as 25(OH)D levels <20 ng/ml (50 nmol/
l) and 25(OH)D between 20 and 29 ng/ml (50 nmol/l and
75 nmol/l), although different definitions exist [11]. In
Europe, the mean serum 25(OH)D levels reported in
population-based studies vary from 18 ng/ml (29 nmol/l)
in Italy to 30 ng/ml (75 nmol/l) in Norway [12]. While the
definitions of adequate vitamin D levels differ, it is estim-
ated that one billion people worldwide have vitamin D defi-
ciency [13]. It affects more than 40% of U.S. and European
men and women, and more than 50% of postmenopaus-
al women [3]. In Switzerland, the last population-based
estimation of vitamin D deficiency, based on
25-hydroxyvitamin D (25(OH)D) serum levels, was made
more than 20 years ago (Swiss MONICA project) [14]. At
this time, 6% of the population were clearly deficient (i.e.,
25(OH)D ≤8 ng/ml [≤20 nmol/l]), and a further 34% had a
low concentration of vitamin D (i.e., <15 ng/ml [<38 nmol/
l]).
The aims of this study were (1.) to estimate the 25(OH)D
distribution and to update the prevalence of vitamin D in-
sufficiency (defined as 25(OH)D between 20 ng/ml and
29.9 ng/ml [50–75 nmol/l]) and deficiency (defined as
25(OH)D <20 ng/ml [<50 nmol/l]) in the Swiss adult pop-
ulation, and (2.) to identify factors, including linguistic re-
gions, associated with vitamin D status in the Swiss adult
population. Major known factors that influence 25(OH)D
levels, such as sunshine hours, altitude, latitude, ethnicity,
physical activity, diet and supplements were taken into ac-
count. Because there is no data on time trends in vitamin
D levels in Switzerland, we also reported our results with
those from three previous Swiss studies conducted in 1988,
2005, and 2009.
Methods
We used the data from the 2010–2011 Swiss Study on Salt
intake (SSS) [15], its main objective was to estimate diet-
ary salt/sodium intake using 24-hour urine collection in the
Swiss population.
The SSS study is a multicentric population-based study in-
cluding data in ten centres reflecting the geographical and
cultural diversity of the Swiss adult population (≥15 years
old). In the SSS study, the Italian region was oversampled
to allow for a meaningful comparison with the two other
major linguistic regions (i.e. French and German). Samp-
ling was stratified using eight age- (15–29 years, 30–44
y, 45–59 y, ≥60 y) and -sex strata. Recruitment began in
January 2010 and ended in August 2011. Information let-
ters were followed by phone calls with up to 3 attempts
on different days, including evening hours, during which
people are more likely to be at home. Participation rate
was low (10%). Because of important difficulties in re-
cruiting young participants, we had to complete the study
sample (aged 15–20 years old) by recruiting volunteers
from schools and universities. Blood collection was not
mandatory to participate in the study.
Subjects were identified by means of the Swiss Federal
Statistical Office phone directory which is regularly up-
dated by the major Swiss phone provider. We performed a
two-stage sampling strategy. Stage 1 identified households
(primary unit) and stage 2 identified a single individual
per household (secondary unit). We determined household
characteristics by phone (household size, age, sex and na-
tionality of its members) to identify the target population,
from which a random sample was then drawn. In the first
stage, we contacted households by phone after having sent
a letter of invitation to participate to the survey. A single
person per household was randomly selected to respond to
a first questionnaire by phone. In the second stage, the se-
lected person came to the study centre on two consecutive
mornings for measurement by a trained health professional
from the survey team and for urine collection.
The phenotypes were collected and the urine samples were
analysed centrally in the laboratory of Lausanne University
Hospital. To minimise the non-response rate multiple at-
tempts to contact participants including outside of regular
working hours were made. The cost of the participants’
transportation was covered by the protocol.
The SSS complied with the Declaration of Helsinki and
was approved by the local Institutional Ethics Committees.
All participants gave written informed consent. For parti-
cipants below age 18 years, written consent from one par-
ent or a legal representative was obtained.
Weight and height were measured and BMI calculated as
weight/height2. Diabetes was based on presence of antidia-
betic drug treatment. Post-menopausal status, use of oral
contraceptive or hormone replacement therapy, ethnicity,
and smoking status were self-reported.
Information on diet (fish, meat, beer, and wine consump-
tions), physical activity and daily minutes of walk were
collected using questionnaires. Participants were asked to
report their medication and supplements. This list of repor-
ted medications/supplements was compared to the origin-
al medicines Compendium® of Switzerland database (ht-
tp://www.compendium.ch/) to identify vitamin D supple-
ments and treatments.
Total serum calcium was measured by O-cresolphtalein
and albumin by bromocresol green; albumin-corrected cal-
cium was then calculated. Creatinine was measured using
Jaffe kinetic compensated method (Roche Diagnostics,
Switzerland), kidney function was calculated using the
Chronic Kidney Disease Epidemiology Collaboration
(CKD-EPI) equation [16]. 24-hour urinary calcium excre-
tion was used as a proxy of hormonal status (e.g., para-
thyroid hormone).
Participants were geocoded by merging information on the
participant’s private address with latitude, longitude and
altitude information using Python programming and
Google Maps Find Altitude software (ht-
tps://developers.google.com/maps/documentation/eleva-
tion/). Data on sunshine hours were obtained from Meteo-
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swiss which collects sunshine hours using meteorological
stations distributed throughout Switzerland (ht-
tp://www.meteoswiss.admin.ch/web/en.html). For each
participant, data on sunshine hours collected in the station
nearest to the participants’s address was used. The expos-
ure period considered in this study was starting from the
month before the participant’s day of blood collection and
was used to estimate the monthly mean sunshine hours.
Vitamin D (25(OH)D3 and 25(OH)D2) concentrations in
serum were measured by liquid chromatography- tandem
mass spectrometry (LC-MS/MS) in the laboratories of the
Swiss Federal Office of Public Health. An in-house val-
idated method with hexadeuterated 25(OH)D3 as internal
standard (IS) was developed. This takes into account the
difficulty of measuring the serum 25(OH)D level over a
long period of time ensuring the comparability of results, as
discussed for NHANES and for the UK national diet survey
[17, 18]. The C-3 epimer of 25(OH)D3 was not chroma-
tographically separated and hence added to the measured
25(OH)D concentration. NIST SRM 972 reference materi-
al [19] was used during validation of the method and again
every sixth month during routine detection. Five different
reference sera were used in each assay. During the whole
measurement period the laboratory participated success-
fully in a quality control programme (DEQAS) [20]. The
limits of quantification of the method were 1.5 ng/ml for
25(OH)D3 and 1.0 ng/ml for 25(OH)D2. Intra- and inter-as-
say coefficient of variation for 25(OH)D3 were 4% and 8%,
respectively. If one of the reference sera showed more than
15% deviation from the target value the results were dis-
carded and the assay repeated.
The stability of the frozen sera with respect to the measured
parameters was tested over a period of 2 years. The effect
of freezing thawing cycles on serum levels was also
checked and we observed no difference with fresh serum
for up to 5 cycles. The sera were stored frozen at –40 °C
and were thawed just before analysis.
Samples for analysis were prepared as follows: 400 µl ac-
tonitrile and 50 µl IS in acetonitrile followed by 150 µl
of serum were pipetted into a 96-well-protein-filtration-
plate, adequately mixed and vacuum filtered into a 96-well-
plate. 250 µl of the resulting solution was injected into the
online-SPE-LC-MS/MS (online SPE: Symbiosis Pharma
from Spark; LC-MS/MS: API5000 from ABSciex; SP-cart-
ridge: Hysphere C8 EC-SE10; analytical column: BDS
Hypersil C8 3 µm, 50×2.1 mm; elution with a water meth-
anol gradient with 0.05% formic acid). Atmospheric pres-
sure chemical ionisation in the positive ion mode was used.
The following transitions were used for quantitation:
25(OH)D3, m/z 401 à 383; 25(OH)D2 m/z 395 à 269; IS
m/z 407/263. For each considered molecule two additional
transitions were used as qualifiers.
We compared current vitamin D levels in the Swiss popu-
lation with previously available Swiss data from the Swiss
MONICA project and from two cohort studies, the Swiss
Red Cross study (Schweizerisches Rotes Kreuz, SRK) and
the Selenium study. The Swiss MONICA project was con-
ducted between October 1988 and June 1989 on a repres-
entative sample of the population from three Swiss can-
tons: Vaud, Fribourg, and Tessin (n = 3,466) [14]. Data
were extracted from published results.
In the Selenium study, 1,847 samples were collected during
the periods of May to July 2005 and May to September
2006. The study design and sampling procedure have been
described previously [21].
In the SRK study (personal communication, manuscript in
preparation), some 120 samples were obtained each month
between December 2009 and November 2010 from the re-
gion of Bern (for a total of 1,582 samples). The sampling
was designed to have a representative sample of blood
donors with respect to sex and age. Serum samples in
the SRK and Selenium studies were obtained from regular
blood donors in blood bank centres of the Swiss Red Cross.
In the SRK and the Selenium studies, 25(OH)D concentra-
tion was assessed by the same analytical method as the one
used in the present study (i.e. Swiss Study on Salt Intake)
while in the MONICA study vitamin D was measured by
radioimmunoassay.
Statistics
Statistical analyses were performed using Stata 11.0 (Stata
Corp, College Station, USA). Continuous variables were
expressed as mean ± standard deviation (s.d.) or 95% con-
fidence intervals (95%CI). Categorical variables were ex-
pressed as number of subjects and percentage. Overall dif-
ference in means and frequencies across groups were tested
(and p-values reported) using design-adjusted Student t-test
and Χ2 tests [22]. For these analyses, serum 25(OH)D was
transformed using the square-root transformation and es-
timates were then back-transformed. Mean 25(OH)D levels
were adjusted for age, sex, BMI, latitude, altitude, mean
sunshine hours, weekly walking hours, period of the year,
and speaking-regions, when appropriate. Adjusted
25(OH)D mean levels are reported by vitamin D supple-
ments/treatment status. Vitamin D status was categorised
into sufficiency, insufficiency, and deficiency defined re-
spectively as 25(OH)D ≥30 ng/ml [75 nmol/l], 20–29.9 ng/
ml [50–75 nmol/l], and <20 ng/ml [50 nmol/l] according to
experts recommendations [3, 23]. To account for the strat-
ified sampling method and Italian-speaking region over-
sampling, we used STATA survey procedures to estimate
means and prevalences of vitamin D levels and status.
To analyse the associations of covariates of interest with
vitamin D status, we used monthly-specific tertiles of
25(OH)D as the dependant variable. For each month of
the study period, the distribution of 25(OH)D is used to
define the specific tertiles of 25(OH)D. The tertiles of the
25(OH) distribution restricted to blood samples conducted
during the month of August were computed. Similarly, the
tertiles of the 25(OH)D distribution were computed separ-
ately for each month of the year so that each month has
specific tertiles of 25(OH)D. This approach is considered
as the most valid measure of associations [24]. Multivari-
ate linear and ordinal logistic regressions were conducted
for vitamin D levels and vitamin D monthly-specific ter-
tiles, respectively. We considered anthropometric, behavi-
oural, biological, and environmental factors as variables of
interest in the analyses. These variables were considered
given their reported or potential influence on vitamin D
level. To identify factors to be kept in multivariate mod-
els, univariate associations between vitamin D and attrib-
utes of interest were tested. Significances of p-values for
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keeping the attribute in the full model were set at <0.10.
Regression diagnostics, including check for collinearity,
were performed and the final models constructed accord-
ingly. We considered oral contraceptive and hormone re-
placement therapy separately in sensitivity analyses. Sig-
nificances of p-values for difference across groups and
p-values for trends were set at <0.05. Conversion factor for
25(OH)D: 1 ng/ml = 2.496 nmol/l.
For the purpose of this analysis, BMI was categorised into
<25.0 kg/m2, 25.0–29.9 kg/m2, ≥30 kg/m2; ethnicity was
defined as Caucasian versus non-Caucasian; smoking
status as never, current, and ex-smokers; high wine and fish
consumptions were both defined as consumption of these
items 3 or more days per week; physical activity was cat-
egorised as nearly never, <1×/month to 1×/week, and at
least 2×/week, and tertiles of daily average minutes of walk
were used.
Results
The present analyses were restricted to participants with
all variables of interest available (93%). A total of 1,309
subjects were included in the analysis. Characteristics by
speaking region are detailed in table 1. The following char-
acteristics statistically differed across regions: BMI (lower
in the Italian-speaking region than in the other two re-
gions), current smokers, albumin-corrected calcium, alti-
tude, latitude, monthly sunshine hours, wine and fish con-
sumptions, and times per week of physical exercise.
The overall adjusted mean 25(OH)D level was 23.1 ng/ml
(57.7 nmol/l) (95%CI: 22.6–23.6 [56.4–58.9]). The adjus-
Figure 1
Adjusted mean 25(OH)D levels. A By period of the year. B By
speaking region. C By BMI categories.
ted 25(OH)D mean was associated with the period of the
year and speaking regions (fig. 1, panel A and B). Among
all subjects, the adjusted 25(OH)D mean was 22.1 ng/ml
(55.2 nmol/l) (20.3–24.1 ng/ml [50.7–60.2 nmol/l]), 22.9
ng/ml (57.2 nmol/l) (95%CI: 21.2–24.6 [52.9–61.4]), and
26.1 ng/ml (65.1 nmol/l) (95%CI: 23.2–29.1 [57.9–72.6]),
respectively in the French-, German-, and Italian-speaking
regions (p-value <0.001). The numbers (%) of participants
not taking vitamin D supplementation or treatment by
speaking regions were as follows: French-speaking n =
362 (95.3%), German-speaking n = 707 (96.2%), Italian-
speaking n = 188 (96.9%). Differences across speaking re-
gions remained significant when restricted to participants
without vitamin D supplements or treatments: 21.7 ng/ml
(54.2 nmol/l) (95%CI: 19.8‒23.7 [49.4–59.2]), 22.6 ng/ml
(56.4 nmol/l) (95%CI: 20.9–24.4 [52.2–60.9]), and 25.6
ng/ml (63.9 nmol/l) (95%CI: 22.9–29.0 [57.2–72.4]), p-
value <0.001.
Overall, the adjusted 25(OH)D mean was 29.0 ng/ml (72.4
nmol/l) (95%CI: 28.0–30.1 [69.9–75.1]), 22.1 ng/ml (55.2
nmol/l) (95%CI: 21.0–23.2 [52.4–57.9]), 17.2 ng/ml (42.9
nmol/l) (95%CI: 16.1–18.3 [40.2–45.7]), and 23.2 ng/ml
(57.9 nmol/l) (95%CI: 22.3–24.1 [55.7–60.2]), respect-
ively, in the July-September, October-December, January-
March, and April-June periods (p-value <0.001). The num-
bers (%) of participants not taking vitamin D supplement-
ation or treatment by period of the year were as follows:
July-September n = 344 (95.6%), October-December n =
250 (94.3%), January-March n = 283 (96.9%), April–June
n = 380 (96.9%). Differences across periods of the year re-
mained significant when restricted to participants without
vitamin D supplements or treatments: 28.9 ng/ml (72.1
Figure 2
A 25(OH)D distribution by speaking regions. B 25(OH)D distribution
by speaking regions, stratified by BMI categories.
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nmol/l) (95%CI: 27.8–30.0 [69.4–74.9]), 21.6 ng/ml (53.9
nmol/l) (20.5–22.8 [51.2–56.9]), 16.9 ng/ml (42.2 nmol/
l) (95%C)I: 15.8-18.0 [39.4–44.9]), and 22.9 ng/ml (57.2
nmol/l) (95%CI: 22.0–23.8 [54.9–59.4]), p-value <0.001.
Adjusted 25(OH)D means also differed by BMI categories
(fig. 1, panel C). Among all subjects, the adjusted mean of
25(OH)D was 24.3 ng/ml (60.7 nmol/l) (95%CI: 23.6–25.1
[58.9–62.6]), 22.3 ng/ml (55.7 nmol/l) (95%CI: 21.3–23.2
[53.2–57.9]), and 20.3 ng/ml (50.7 nmol/l) (95%CI:
19.0–21.7 [47.4–54.2]), respectively in the normal, over-
weight, and obese categories (p-value <0.001). Differences
across BMI categories remained significant when restricted
to participants without vitamin D supplements or treat-
ments (data not shown).
Figure 2 shows the distribution of 25(OH)D levels (ng/ml)
by speaking region overall (panel A) and stratified by BMI
categories (panel B). Overall and for each BMI categories,
the distribution of 25(OH)D levels in the Italian-speaking
region was shifted to higher values when compared with
the French and German-speaking regions’ distributions.
Table 2 shows the prevalences of vitamin D sufficiency, in-
sufficiency, and deficiency, by seasons, gender, and BMI
categories. The prevalences of vitamin D insufficiency and
deficiency were the highest in the January‒March period;
26.4% (21.6–31.7) and 61.6% (56.0–67.0), respectively.
Figure 3
A Variation of the serum 25-hydroxyvitamin D distribution per month
of examination for different studies. Lower and upper lines
represent the 25th and 75th percentiles, respectively. The area
between the 25th and 75th percentiles of our study is shaded (red)
to enhance the readability of the data. Measured values are given
in ng/ml (right axis) and nmol/l (left axis). Selenium and MONICA
studies were not conducted over a full year and data points are
therefore missing. B Variation of the serum 25-hydroxyvitamin D
medians per month of examination for different studies.
Restricted to non vitamin D supplements or treatment
users, these prevalences were 25.4% (20.7–30.8) and
63.6% (57.8–69.0), respectively. The prevalence of vitamin
D insufficiency or deficiency was highest among men
throughout all period of the year; in the January‒March
period, more than 9 of ten men were vitamin D insufficient
or deficient. Among participants with obesity (i.e., BMI
≥30 kg/m2), the prevalences of vitamin D insufficiency
and deficiency in the January‒March period were 21.3%
(11.8–35.2) and 68.1% (53.6–79.8), respectively.
Prevalences of vitamin D sufficiency, insufficiency, and de-
ficiency, by speaking regions, gender, and BMI categor-
ies are shown in table 3. The Italian-speaking region stood
out with the lowest prevalence of vitamin D insufficiency
or deficiency (74.2%, 76.4%, and 59.8% in the French-
, German-, and Italian-speaking regions, respectively, p-
value <0.001). Compared to the French and German-speak-
ing regions, the prevalence of vitamin D insufficiency or
deficiency in the Italian-speaking region remained lower
in men, women, and in participants with BMI <25 kg/m2.
There were no significant differences in vitamin D insuf-
ficiency or deficiency prevalences across speaking regions
among participants who were overweight or obese.
Determinants of vitamin D status
Multivariate associations of characteristics with vitamin D
monthly-specific tertiles are reported in table 4. An odds
ratio greater than the null value (OR >1) in the table 4 sug-
gests that the factor is associated with an increased likeli-
hood of being in an upper 25(OH)D monthly-specific ter-
tile than in the absence (otherwise mentioned) of the factor.
Conversely, an odds ratio lower than the null value (OR <1)
suggests that the factor is associated with a decreased like-
lihood of being in an upper 25(OH)D tertile than in the ab-
sence (otherwise mentioned) of the factor. BMI was neg-
atively associated with vitamin D monthly-specific tertiles;
each unit increase of BMI was associated with an 8% de-
creased likelihood of being in a higher vitamin D tertiles.
Oral contraceptive, altitude, urinary excretion of calcium,
use of vitamin D supplement or treatment, high wine con-
sumption, physical activity were positively associated with
vitamin D monthly-specific tertiles. In sensitivity analyses,
oral contraceptive and not hormone replacement therapy
drove the association (data not shown). Compared to the
French-speaking region and after adjustment, the Italian-
speaking region was associated with a higher likelihood
of being in a higher vitamin D tertiles (OR: 1.66, 95%CI:
1.14–2.43).
Previous Swiss 25(OH)D studies
The variation of 25(OH)D distribution during the examin-
ation year is depicted in figure 3 across four Swiss stud-
ies. The winter nadir (February‒March) is almost identical
in all studies whereas the fluctuation of summer apex
(August-September) across studies is slightly larger. No
major and systematic differences across studies are ob-
served.
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Discussion
In this population-based study, we show that the prevalence
of vitamin D insufficiency or deficiency in the Swiss adult
population is high and varies by period of the year, BMI
categories, and speaking regions. The association of
speaking-regions with vitamin D status was independent of
major potential confounders.
The overall prevalence of vitamin D deficiency or insuf-
ficiency was 74.7% and increased to 76.0% among par-
ticipants not taking vitamin D supplement or treatment.
While the health impact of vitamin D insufficiency is de-
bated [25], 39.5% of the participants not taking vitamin
D supplement or treatment (95.9% of our overall sample)
presented a vitamin D level <20 ng/ml (50 nmol/l) (i.e. vit-
amin D deficiency). Current evidence supports the notion
that 25(OH)D concentrations of at least 20 ng/ml (50 nmol/
l) are necessary to support bone health in all adults and
muscle health in older adults [26].
Most of the vitamin D is produced in the skin from
7-dehydrocholesterol by sunlight UVB exposure. In a re-
gion such as Switzerland (latitude about 45 o) vitamin D
effective UVB radiation is lower in the winter and fall
periods than in the spring and summer periods [27]. The
highest prevalence of vitamin D insufficiency and defi-
ciency in our study were observed during the Octo-
ber‒December and January‒March periods. Thus, when
there is ineffective exposition to sunlight, sufficient vitam-
in D levels are clearly not reached in the Swiss adult pop-
ulation. There is no evidence showing that adequate level
throughout the seasons is essential for vitamin D to be be-
neficial, notably for bone or muscle health outcomes. Yet,
given the central roles of vitamin D in regulating calci-
um absorption, promoting bone resorption and maintaining
calcium and phosphate levels for bone formation, it seems
very unlikely that vitamin D deficiency during meaningful
periods of the year is without any biological and health im-
plications.
Vitamin D levels and prevalence were also clearly associ-
ated with BMI. This is in line with previous studies [28].
There are several mechanisms by which vitamin D levels
could be inversely associated with BMI including the de-
crease of outdoor physical activity, the inadequate diet, and
the sequestration of vitamin D in the cutaneous fat among
people with overweight or obesity [29]. The reason for the
increasing prevalence of vitamin D deficiency observed in
the United States could be in part due to the increase of
BMI [30].
The mean level of 25(OH)D in the Swiss adult population
(about 23 ng/ml [57 nmol/l]) is similar to Western
European countries (e.g., 20 ng/ml [50 nmol/l] in France),
higher than Southern European countries (e.g., 18 ng/ml
[45 nmol/l] in Italy), and lower than Northern European
countries (e.g., 30 ng/ml [75 nmol/l] and 27 ng/ml [67
nmol/l] in Norway and Sweden, respectively) [12]. The
higher and lower serum 25(OH)D levels in Northern and
respectively Southern European countries, are probably
Table 1: Characteristics of the 1,309 individuals from the Swiss Study on Salt Intake included in the analyses, by region.
All regions
(n = 1309)
French-speaking
(n = 380)
German-speaking
(n = 735)
Italian-speaking
(n = 194)
p-value
Mean or % SD Mean or % SD Mean or % SD Mean or % SD
Age (years) 48.8 18.2 48.1 17.3 49.4 17.3 46.9 28.4 0.18
Women gender (%) 51.3 – 51.8 – 51.0 – 51.5 – 0.93
Body mass index (kg/m2) 25.4 4.6 25.4 4.8 25.4 4.2 24.5 6.4 0.03
Body mass index category (%) 0.06
<25 kg/m2 52.2 – 53.8 – 50.3 – 61.9 –
25.29.9 kg/m2 33.5 – 30.3 – 35.9 – 25.8 –
30+ kg/m2 14.4 – 15.8 – 13.8 – 13.4 –
Diabetes (%) 2.8 – 2.6 – 2.9 – 2.6 – 0.94
Menopause (%) 22.6 – 23.6 – 22.4 – 20.0 0.67
Oral contraceptive (%) 17.2 – 20.0 – 15.7 – 17.5 – 0.11
Caucasian ethnicity (%) 98.3 – 97.6 – 98.4 – 100.0 0.31
Current smoker (%) 16.7 – 20.8 – 14.8 – 14.9 – 0.014
Albumin-corrected calcium (mmol/l) 2.30 0.1 2.27 0.1 2.32 0.1 2.29 0.1 <0.001
Altitude (meters) 487.6 188.6 545.1 233.7 470.3 125.7 367.5 237.5 <0.001
Latitude (degrees) 47.0 0.5 46.4 0.2 47.4 0.2 46.1 0.2 <0.001
Mean monthly sunshine (hours) 4.6 2.4 6.2 1.7 3.7 2.2 5.6 1.6 <0.001
Urinary excretion of calcium (mmol / 24 h) 4.0 2.4 4.2 2.4 4.0 2.2 4.0 3.9 0.38
Vitamin D supplement or treatment (%) 4.1 – 4.7 – 3.8 – 3.1 – 0.56
High wine consumption (%) 35.6 – 42.6 – 32.8 – 28.4 – <0.001
High fish consumption (%) 5.8 – 9.8 – 4.0 – 4.2 – <0.001
Daily average walk (minutes) 58.3 73.0 53.1 53.5 60.9 76.8 58.9 111.0 0.16
Tertiles of daily average walk (%) 0.52
Lower tertile 55.8 – 58.1 – 54.8 – 53.8 –
Middle tertile 24.4 – 21.8 – 25.7 – 25.3 –
Upper tertile 19.8 – 20.2 – 19.5 – 20.9 –
Times per week of physical activity (%) <0.001
Nearly never 16.6 – 25.1 – 11.7 – 21.5 –
<1×/month to 1×/week 33.3 – 30.7 – 34.2 – 37.7 –
At least 2×/week 50.1 – 44.1 – 54.1 – 40.8 –
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mediated by the high intake of fish and cod liver oil in
Northern countries, and by skin pigmentation and sunshine
avoiding behaviors in Southern countries [12].
Reasons for the better status in vitamin D among subjects
in the Italian-speaking region compared to subjects in the
French- and German-speaking regions are not clear. One
possible explanation is residual confounding. We adjusted
for sunshine hours, altitude, and latitude because theoretic-
ally, persons living in regions with greater sunshine hours,
higher altitude, and lower latitude should present higher
levels of vitamin D than persons in regions without these
characteristics [27]. In practice however, since more than
90% of vitamin D arises from sunlight (in the absence of
supplementation), vitamin D levels also depend on cultur-
al behaviours such as clothing, time spent outdoor, sun-
bathing habits [31]. Although we adjusted for physical
activity and weekly hours of walking to account for the
time spent outdoors, we missed information on other beha-
viours that might influence vitamin D levels. It is unlikely
that differences in skin pigmentation explain the highest
vitamin D levels in the Italian-speaking region. While we
cannot exclude residual confounding, the strong associ-
ation of vitamin D status with speaking regions in Switzer-
land deserve attention and should be further explored.
Our analyses show that vitamin D is independently associ-
ated with BMI, altitude, and vitamin D supplements/med-
ications, which is consistent with previous reports [30, 32,
33]. We also report associations of vitamin D levels with
oral contraceptive/hormone replacement therapy and wine
consumption. Oral contraceptive use increases circulating
levels of 25OHD, likely because estrogen increases vit-
amin D binding protein expression and stimulates the ren-
al 1,alpha-hydroxylase [34, 35]. We considered oral con-
traceptive and hormone replacement therapy separately in
sensitivity analyses and found that oral contraceptive and
not hormone replacement therapy drove the association.
Molecular evidence suggests that phytoestrogens such as
the resveratrol present in red wine may regulate the vitamin
D receptor promoter and could enhance the effects of vit-
amin D [36]. Vitamin D could therefore mediate part of the
effects and mechanisms of action of red wine consumption
on the risk of CVD [37]. Our results confirmed that inform-
ation on contraceptive use and wine consumption should be
considered when interpreting 25OHD values.
Although limited, data from the literature suggest that the
prevalence of vitamin D deficiency has increased this past
decade. For example, age-adjusted mean serum 25(OH)D
concentrations were 5–20 nmol/l lower in NHANES
2000–2004 than in NHANES III (1988–1994) [30, 38].
Reasons for increasing prevalence of vitamin D deficiency
are not clear but include the increase in BMI [30]. Trends
data on 25(OH)D levels based on a same source population
in Switzerland are currently lacking. When comparing the
25(OH)D levels of the 2010–2011 SSS study to those of
the 1988–1989 Swiss MONICA project and the 2009–2010
SRK and 2005–2006 Selenium studies for identical periods
Table 2: Prevalence of vitamin D sufficiency (30+ ng/ml), insufficiency (20–29.9 ng/ml), and deficiency (<20 ng/ml)*, by characteristics and period.
Analysis by season
All year (Jan‒Dec) Jul‒Sept Oct‒Dec Jan‒Mar Apr‒Jun p-value
% 95%CI % 95%CI % 95%CI % 95%CI % 95%CI
All subjects <0.001
25(OH)-D 30+ ng/ml* 25.3 23.0–27.8 44.0 38.7–49.4 22.0 17.4–27.6 12.0 8.7–16.2 22.8 18.8–27.3
25(OH)-D 20–29.9 ng/ml 36.5 33.9–39.2 39.1 33.9–44.5 35.5 29.8–41.6 26.4 21.6–31.7 43.2 38.3–48.3
25(OH)-D <20 ng/ml 38.2 35.5–40.9 16.9 13.2–21.4 42.5 36.5–48.7 61.6 56.0–67.0 34.0 29.4–39.0
Non-supplement users <0.001
25(OH)-D 30+ ng/ml 24.0 21.7–26.5 43.1 37.8–48.7 20.0 15.4–25.5 11.0 7.8–15.2 21.6 17.6–26.2
25(OH)-D 20–29.9 ng/ml 36.5 33.8–39.3 39.1 33.8–44.6 36.1 30.2–42.4 25.4 20.7–30.8 43.7 38.7–48.9
25(OH)-D <20 ng/ml 39.5 36.7–42.3 17.8 13.9–22.5 44.0 37.7–50.4 63.6 57.8–69.0 34.7 29.9–39.7
Men <0.001
25(OH)-D 30+ ng/ml 20.4 17.4–23.8 36.6 29.4–44.6 15.9 10.7–23.1 7.9 4.4–13.6 20.8 15.5–13.6
25(OH)-D 20–29.9 ng/ml 38.5 34.7–42.4 44.9 37.1–53.0 40.9 32.8–49.5 25.0 18.5–32.9 42.3 35.4–49.6
25(OH)-D <20 ng/ml 41.1 37.2–45.1 18.4 12.9–25.6 43.1 34.8–51.9 67.1 58.9–74.4 36.9 30.2–44.1
Women <0.001
25(OH)-D 30+ ng/ml 29.9 26.5–33.6 50.3 43.0–57.7 28.4 21.0–37.1 15.8 10.8–22.5 24.7 19.1–31.3
25(OH)-D 20–29.9 ng/ml 34.6 31.0–38.4 34.1 27.4–41.4 29.8 22.4–38.5 27.6 21.1–35.3 44.1 37.2–51.2
25(OH)-D <20 ng/ml 35.5 31.8–39.3 15.6 10.9–21.8 41.8 33.3–50.8 56.6 48.6–64.2 31.2 25.0–38.2
BMI <25 <0.001
25(OH)-D 30+ ng/ml 31.1 27.7–34.7 54.7 47.2–62.0 26.9 20.0–35.3 13.7 8.9–20.4 27.2 21.5–33.6
25(OH)-D 20–29.9 ng/ml 38.4 34.8–42.2 35.2 28.4–42.6 35.9 28.1–44.5 30.9 23.8–39.1 47.8 41.1–54.6
25(OH)-D <20 ng/ml 30.4 27.0–34.1 10.1 6.4–15.6 37.2 29.2–45.9 55.4 47.1–63.4 25.1 19.7–31.4
BMI 25–29.9 <0.001
25(OH)-D 30+ ng/ml 20.7 17.1–24.8 38.3 28.9–48.6 18.9 12.2–28.1 10.6 6.0–18.1 18.1 12.2–26.0
25(OH)-D 20–29.9 ng/ml 35.1 30.6–39.8 41.3 31.7–51.6 37.2 28.1–47.3 23.1 16.0–32.1 39.7 31.3–48.6
25(OH)-D <20 ng/ml 44.2 39.4–49.1 20.4 13.3–29.9 43.9 34.1–54.1 66.3 56.8–74.7 42.2 33.7–51.2
BMI 30+ 0.010
25(OH)-D 30+ ng/ml 15.7 11.1–21.8 22.7 14.0–34.6 10.8 3.5–28.6 10.6 4.5–23.2 15.2 7.0–29.9
25(OH)-D 20–29.9 ng/ml 32.8 26.3–40.1 46.7 34.4–59.3 28.0 14.8–46.5 21.3 11.8–35.2 30.2 18.4–45.4
25(OH)-D <20 ng/ml 51.5 44.1–58.8 30.6 20.2–43.5 61.2 42.7–77.0 68.1 53.6–79.8 54.6 39.5–68.8
* Expressed in nmol/l, these categories correspond to vitamin D sufficiency (>75 nmol/l), insufficiency (50‒75 nmol/l), and deficiency (<50 nmol/l)
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of the year, we observed no major change in the last two
decades. We acknowledge the limitation of this comparison
given the difference in methodologies and study designs.
These comparisons must therefore be interpreted with cau-
tion.
These results should be interpreted in the light of the
study’s strengths and limitations. This is the first
population-based study covering the three linguistic re-
gions of Switzerland, taking into account geographical and
meteorological information. We measured vitamin D status
(25(OH)D) by the gold standard technique (LC-MS/MS).
Information on major known potential confounders was
available. However, despite these efforts, information is
still incomplete. For example, information on the darkness
of the skin was missing and we used self-reported ethnicity
to categorise participants into Caucasians and non-Caucasi-
ans. In fact, the packaging and size of melanosomes in the
keratocytes influence darkness of the skin, and dark pig-
ment does reduce the skin’s ability to synthesise vitamin D
from sunlight by up to 95% [33, 39]. However, the propor-
tion of non-Caucasians was very low in the studied popula-
tion, so this aspect is very unlikely to explain the observed
low levels of vitamin D.
We did not use a comprehensive food frequency question-
naire. Diet however, contains only small amounts of vitam-
in D (i.e., vitamin D3 or vitamin D2), and information on
fish consumption was collected, which is the major dietary
source of vitamin D in humans. We did not take air pol-
lution, ozone, time of the day, reflectivity and cloud cov-
er into account. These weather-related factors do influence
vitamin D effective radiation and thus vitamin D photosyn-
thesis [27], although the impact is likely to be minor.
The prevalence of vitamin D deficiency and insufficiency
depends on the definition used. We have based our analyses
on the most recent definition of vitamin D deficiency by
the 2011 US Report on Dietary Reference Intakes for Cal-
cium and Vitamin D from the Institute of Medicine (IOM)
[25]. The IOM committee concluded that a serum
25-hydroxyvitamin D level of 20 ng/ml (50 nmol/l) is de-
sirable for bone and overall health. While vitamin D de-
ficiency defined as a serum 25(OH)D of <20 ng/ml (50
nmol/l), and vitamin D insufficiency defined as a 25(OH)D
of between 20 and 29 ng/ml (50–75 nmol/L) have been
extensively used in epidemiological studies, the definition
of vitamin D insufficiency is more controversial [25]. Of
note, a 25(OH)D level of at least 20 ng/ml (50 nmol/l) was
chosen by the IOM to define the vitamin D recommended
dietary allowances of 600 IU/day for ages 1–70 years and
800 IU/day for ages 71 years and older, to meet the require-
ments of at least 97.5% of the population.
The low participation rate limits the external validity of our
findings. We explain the low participation rate in the SSS
study by the unattractiveness of 24-hour urine collection,
which necessitates two visits to the health centre, togeth-
er with the two-stage sampling strategy, which implies that
the person we contacted by phone was not automatically
Table 3: Prevalence of vitamin D sufficiency (30+ ng/ml), insufficiency (20‒29.9 ng/ml), and deficiency (<20 ng/ml)*, by characteristics and region.
Analysis by regionAll regions
French-speaking German-speaking Italian-speaking
p-value
% 95%CI % 95%CI % 95%CI % 95%CI
All subjects <0.001
25(OH)-D 30+ ng/ml* 25.3 23.0–27.8 25.8 21.6–30.4 23.5 20.6–26.7 40.2 33.5–47.3
25(OH)-D 20–29.9 ng/ml 36.5 33.9–39.2 38.2 33.4–43.2 35.2 31.9–38.7 40.2 33.5–47.3
25(OH)-D <20 ng/ml 38.2 35.5–40.9 36.0 31.4–41.0 41.2 37.7–44.8 19.6 14.6–25.8
Non-supplement users <0.001
25(OH)-D 30+ ng/ml 24.0 21.7–26.5 24.3 20.2–29.0 22.2 19.3–25.4 39.9 33.1–47.1
25(OH)-D 20‒29.9 ng/ml 36.5 33.8–39.3 38.1 33.2–43.2 35.4 31.9–38.9 39.9 33.1–47.1
25(OH)-D <20 ng/ml 39.5 36.7–42.3 37.6 32.7–42.7 42.4 38.8–46.1 20.2 15.1–26.6
Men 0.002
25(OH)-D 30+ ng/ml 20.4 17.4–23.8 18.0 13.1–24.3 19.7 15.9–24.2 39.4 30.0–49.6
25(OH)-D 20-29.9 ng/ml 38.5 34.7–42.4 38.2 31.5–45.5 38.1 33.2–43.2 43.6 33.9–53.8
25(OH)-D <20 ng/ml 41.1 37.1–45.1 43.7 36.7–51.0 42.2 37.2–47.4 17.0 10.7–26.0
Women <0.001
25(OH)-D 30+ ng/ml 29.9 26.5–33.6 33.0 26.8–39.9 27.2 22.9–31.9 41.0 31.8–50.1
25(OH)-D 20-29.9 ng/ml 34.6 31.0–38.4 38.1 31.5–45.1 32.5 28.0–37.4 37.0 28.1–46.9
25(OH)-D <20 ng/ml 35.4 31.8–39.3 28.9 23.0–35.7 40.2 35.4–45.3 22.0 14.9–31.2
BMI <25 <0.001
25(OH)-D 30+ ng/ml 31.1 27.7–34.7 35.3 29.0–42.1 26.9 22.6–31.7 45.8 37.1–54.8
25(OH)-D 20–29.9 ng/ml 38.4 34.8–42.2 40.2 33.7–47.1 37.5 32.7–42.6 38.3 30.1–47.3
25(OH)-D <20 ng/ml 30.4 27.0–34.1 24.5 19.2–30.9 35.6 30.9–40.6 15.8 10.3–23.5
BMI 25–29.9 0.121
25(OH)-D 30+ ng/ml 20.7 17.1–24.8 16.5 10.8–24.5 21.7 17.1–27.1 32.0 20.6–46.1
25(OH)-D 20–29.9 ng/ml 35.1 30.6–39.8 33.9 25.8–58.6 35.0 29.5–40.9 44.0 31.0–57.9
25(OH)-D <20 ng/ml 44.2 39.4–49.1 49.6 40.5–58.6 43.3 37.5–49.4 24.0 14.2–37.7
BMI 30+ 0.141
25(OH)-D 30+ ng/ml 15.7 11.1–21.8 11.7 5.7–22.5 16.8 10.7–25.4 29.2 14.6–49.9
25(OH)-D 20‒29.9 ng/ml 32.8 26.3–40.1 40.0 28.4–52.8 27.7 19.9–37.2 41.7 24.1–61.6
25(OH)-D <20 ng/ml 51.5 44.1–58.8 48.3 36.0–60.8 55.4 45.6–64.8 29.2 14.6–49.9
* Expressed in nmol/l, these categories correspond to vitamin D sufficiency (>75 nmol/l), insufficiency (50–75 nmol/l), and deficiency (<50 nmol/l)
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the one randomly selected to enter the study. As a conse-
quence, the contact letter was not directly addressed to the
person who subsequently took part in the study.
Conclusions
Low levels of blood vitamin D are common among Swiss
adults, in particular during winter months, in overweight
and obese adults, and outside the Italian-speaking region.
This is of potential concern considering the role of vitamin
D in key biological processes.
Further epidemiological studies should assess the impact
of vitamin deficiency on the key chronic and degenerative
diseases, and further assess the impact of dietary supple-
ments on the improvement of levels of vitamin D. If con-
sidered as substantial, an experimental introduction of vit-
amin supplement in a population-wide experiment should
be developed, implemented and carefully monitored.
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Figures (large format)
Figure 1
Adjusted mean 25(OH)D levels. A By period of the year. B By speaking region. C By BMI categories.
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Figure 2
A 25(OH)D distribution by speaking regions.
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Figure 2b
B 25(OH)D distribution by speaking regions, stratified by BMI categories.
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Figure 3a
A Variation of the serum 25-hydroxyvitamin D distribution per month of examination for different studies. Lower and upper lines represent the
25th and 75th percentiles, respectively. The area between the 25th and 75th percentiles of our study is shaded (red) to enhance the readability
of the data. Measured values are given in ng/ml (right axis) and nmol/l (left axis). Selenium and MONICA studies were not conducted over a full
year and data points are therefore missing.
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Figure 3b
B Variation of the serum 25-hydroxyvitamin D medians per month of examination for different studies.
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